Overexpression of Bcl-2 or the Bcl-2 family of antiapoptotic proteins is known to induce TRAIL resistance in cancer cells.27 In our study, Med treatment downregulated Bcl-2 and BclxL was suppressed by Med treatment. The gene discussed is BCL2L1; the disease is cancer.